The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.
UAE air forces respond to more missile threats on Friday
UAE President and King of Jordan call for immediate halt to military actions
No injuries after debris incident in central Dubai
H.H. Sheikh Mohammed issues law on violations and penalties
Abu Dhabi expands driverless taxi operations in Yas Island
UAE air defences intercept 10 ballistic missiles and 26 drones on Thursday
UAE allows residents with expired residency visas to re-enter
Sharjah issues public safety guide for emergencies
